Literature DB >> 21085962

Utility of MRI before and after uterine fibroid embolization: why to do it and what to look for.

John Martin Kirby1, David Burrows, Ehsan Haider, Zeev Maizlin, Mehran Midia.   

Abstract

The utility of magnetic resonance imaging (MRI) in the selection, procedure planning, and follow-up of patients undergoing arterial embolization for uterine fibroids is reviewed. Advantages of MRI over ultrasound include multiplanar imaging capability, a larger field of view, increased spatial resolution, improved anatomic detail, and the ability to detect other pelvic disorders. MRI can assess fibroid viability by detecting contrast agent enhancement. Magnetic resonance angiography has a useful role in evaluation of pelvic vasculature. Magnetic resonance parameters such as T1 and T2 relaxation times and diffusion-weighted characteristics have an emerging role in predicting outcome before and after embolization. MRI may be used to evaluate technical success and to image potential complications after embolization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085962     DOI: 10.1007/s00270-010-0029-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  7 in total

1.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

Review 2.  Preprocedural MRI and MRA in planning fibroid embolization.

Authors:  Cristina Maciel; Yen Zhi Tang; Anju Sahdev; António Miguel Madureira; Paulo Vilares Morgado
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

Review 3.  Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.

Authors:  Muhammad O Awiwi; Mohamed Badawy; Akram M Shaaban; Christine O Menias; Jeanne M Horowitz; Moataz Soliman; Corey T Jensen; Ayman H Gaballah; Juan J Ibarra-Rovira; Myra K Feldman; Mindy X Wang; Peter S Liu; Khaled M Elsayes
Journal:  Abdom Radiol (NY)       Date:  2022-05-13

4.  Ineffectiveness of magnetic resonance imaging enhancement to predict fibroid volume reduction after uterine artery embolization.

Authors:  Ginny Bao; Lizbeth Hu; Hearns W Charles; Amy R Deipolyi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

5.  Monitoring Leiomyoma Response to Uterine Artery Embolization Using Diffusion and Perfusion Indices from Diffusion-Weighted Imaging.

Authors:  Mengqiu Cao; Lijun Qian; Xuebin Zhang; Xinjun Suo; Qing Lu; Huilin Zhao; Jialin Liu; Jianxun Qu; Yan Zhou; Jianrong Xu; Shiteng Suo
Journal:  Biomed Res Int       Date:  2017-08-27       Impact factor: 3.411

6.  Quality care guidelines for uterine artery embolisation in women with symptomatic uterine fibroids in Australia and New Zealand: According to the AGREE-II checklist and endorsed by the Interventional Radiology Society of Australasia.

Authors:  Warren Clements; Nicholas Brown; Brendan Buckley; Chris Rogan; Hong Kuan Kok; Eisen Liang
Journal:  J Med Imaging Radiat Oncol       Date:  2022-07-03       Impact factor: 1.667

7.  Shearwave elastographic evaluation of uterine leiomyomas after uterine artery embolization: preliminary results

Authors:  Cesur Samanci; Yilmaz Önal
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.